Galantamine

Aurobindo Pharma Limited🇺🇸 United States

FDA Page

Effective Date: Jan 30, 2024
Approval ID: d0b75970-8d3d-408b-9e17-9cbad0f776b1
Products: 3 registered
Version: 11

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use GALANTAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for GALANTAMINE EXTENDED-RELEASE CAPSULES. GALANTAMINE extended-release capsules, for oral use Initial U.S. Approval: 2001

Quick Stats

Total Products3

Labelers2

Label Sections34

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.